| Authors: |
O'Regan P; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Butt F; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Carter L; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Graham DM; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Le Blanc A; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom.; Research IT, The University of Manchester, Manchester, United Kingdom., Hoskins R; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom.; Research IT, The University of Manchester, Manchester, United Kingdom., Stephenson L; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Patil A; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Shabbir M; Research IT, The University of Manchester, Manchester, United Kingdom., Eken D; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Singh S; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Villa A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Agnelli L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Damian S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Grave C; Research IT, The University of Manchester, Manchester, United Kingdom., Pretelli G; Early Drug Development, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall D'Hebron University Hospital (HUVH), Barcelona, Spain., Garralda E; Early Drug Development, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Department of Medical Oncology, Vall D'Hebron University Hospital (HUVH), Barcelona, Spain., Frost H; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.; Department of Hemato-Oncology, University of Milan, Milan, Italy., Freitas A; Department of Computer Science, The University of Manchester, Manchester, United Kingdom.; IDIAP Research Institute, Martigny, Switzerland., Dive C; Cancer Research UK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom., Unsworth H; Digital Cancer Research Team, CRUK National Biomarker Centre, The University of Manchester, Manchester, United Kingdom. |